Concepedia

A.R. He

AH

Statistics

Publications

2

Citations

49

H-Index

2

Active since

2022

Affiliations

Seoul National University Bundang Hospital(Current)

The Christie NHS Foundation Trust

Tennessee Oncology

Sarah Cannon

Nanjing General Hospital of Nanjing Military Command

A.R. He is an author at Seoul National University Bundang Hospital specializing in cancer survival analysis, combination chemotherapy, and pharmacology.

Publications per year

2022–2022

2

Publications

2

78P Updated overall survival (OS) from the phase III TOPAZ-1 study of durvalumab (D) or placebo (PBO) plus gemcitabine and cisplatin (+ GC) in patients (pts) with advanced biliary tract cancer (BTC)

D-Y. Oh, A.R. He, S. Qin et al. · Annals of Oncology · 2022 · 26 citations

, , +9

56P Updated overall survival (OS) from the phase III TOPAZ-1 study of durvalumab (D) or placebo (PBO) plus gemcitabine and cisplatin (+ GC) in patients (pts) with advanced biliary tract cancer (BTC)

D-Y. Oh, A.R. He, S. Qin et al. · Annals of Oncology · 2022 · 23 citations

, , +10

1–2 of 2